跳至主要内容
临床试验/CTRI/2024/02/063282
CTRI/2024/02/063282进行中(未招募)Unknown

An open label, single-centric, non-randomized clinical study to evaluate the safety and efficacy of a new antimicrobial wound dressing (VELVERT) as an adjuvant therapy in patients having Necrotising soft-tissue infections (NSTI)/ fasciitis

Datt Mediproducts Pvt Ltd,1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2024年2月26日最近更新:

试验速览

阶段
Unknown
状态
进行中(未招募)
入组人数
20
试验地点
1
主要终点
A study outcome will be considered if below end points meet.

研究概览

简要总结

The study enrolled 20 patients with, "Necrotising soft-tissue infections fasciitis" and were treated with an anti-microbial dressing (VELVERT) for a duration of 60 days. Subjects were evaluated at the scheduled visits.

First subject was enrolled on 16-Apr-2024.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Adult male or female subjects within the age group of 18 to 70 years (both inclusive).
  • Subject with HbA1c level below 6.5 % (Well-controlled diabetes mellitus)
  • Subject with soft tissue infection caused by trauma, injury, burn, surgery.
  • Subjects with damaged deep layers of your skin that led to necrosis.

排除标准

  • Exclusion Criteria
  • Subject unwilling or unable to comply with the follow up visits necessary for data collection.
  • Subject found positive for HIV, HBsAg and HCV.
  • Concurrent participation in another clinical trial that involves an investigational drug or dressing that would interfere with this study.
  • Pregnant females.
  • Subject with Immunosuppression, corticosteroids or chemotherapy.
  • Subject with decision making impairment.
  • Allergies to any material contained investigational devices.

结局指标

主要结局

A study outcome will be considered if below end points meet.

时间窗: 60 days

• Lesion/wound healed by 60 days (2 months) or prior

时间窗: 60 days

• Reduction of wound surface area within a time frame of 60 days (2 months). (Change in wound size)

时间窗: 60 days

次要结局

  • • Number of patients achieve a complete wound closure or reduction in wound area by ≥ 50% by 60 days or earlier. (Change in wound area).(• Subject self-assessment of intensity of pain. (Pain scale from 0 to 10))

研究者

申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Dr Sudhir Kumar

Maharani Laxmi Bai Medical College

研究点 (1)

Loading locations...

相似试验